PROLOR BIOTECH, INC.
CIK 0001268659
Revenue (TTM)
$0
Q2 Aug 2013
Net Income (TTM)
−$23.2M
−21.3% YoY
Q2 Aug 2013
EPS Diluted (TTM)
—
Q2 Aug 2013
Gross Margin
—
Q2 Aug 2013
Operating Margin
—
Q2 Aug 2013
Net Margin
—
Q2 Aug 2013
Free Cash Flow (TTM)
−$16.87M
Q2 Aug 2013
Cash
$19.02M
Q2 Aug 2013
Total Debt
—
Q2 Aug 2013
Shares Outstanding
63.85M sh
Q2 Aug 2013
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.